PCOS 2015:ASCO、AAHPM联合发布肿瘤姑息治疗指导声明

2015-10-09 佚名 中国医学论坛报今日肿瘤

美国临床肿瘤学会(ASCO">ASCO)的肿瘤姑息治疗论坛(Palliative Care in Oncology Symposium 2015,PCOS 2015)将于10月9-10日于美国波士顿召开。PCOS 2015新闻发布会在美东时间10月5日下午12时举行。 在2015年肿瘤姑息治疗论坛(PCOS 2015)上,美国临床肿瘤学会(ASCO)和美国宁养与姑息医学会(AAHPM)将联



美国临床肿瘤学会(ASCO">ASCO)的肿瘤姑息治疗论坛(Palliative Care in Oncology Symposium 2015,PCOS 2015)将于10月9-10日于美国波士顿召开。PCOS 2015新闻发布会在美东时间10月5日下午12时举行。

在2015年肿瘤姑息治疗论坛(PCOS 2015)上,美国临床肿瘤学会(ASCO)和美国宁养与姑息医学会(AAHPM)将联合发布一份指导声明。 针对如何达成高质量初级肿瘤姑息治疗,这份声明将提供首个基于共识的推荐。

据指导声明相关研究的首席作者Kathleen Bickel医生介绍,这是首次为实现高质量初级肿瘤姑息治疗设定“合理的、可行的目标”,希望藉此能够提高患者的舒适度及生活质量。

尽管将姑息治疗整合入肿瘤的常规治疗可以改善患者的症状负担、提高患者的生活质量以及治疗满意度,而且ASCO也曾推荐,对于晚期和(或)高症状负荷的肿瘤患者,在抗肿瘤治疗之初就应该同时进行姑息治疗,但是,既往研究也表明,有限的姑息治疗专业团队资源很难满足肿瘤患者的需求。因此,来自肿瘤医学以及姑息医学等领域的专家们试图找到另一种达成姑息治疗的方式——一个多学科专家委员会(包括医生、患者代表、社会工作者、护士等)列举了996种不同的姑息治疗服务名类并按重要性、可行性以及是否在肿瘤治疗临床实践范畴(importance,feasibility,scope)等3个条件将其排序,而在所有3个条件下均排名前列的服务类别将被列入“高质量初级肿瘤姑息治疗(high-quality primary palliative care in oncology)”定义名单。这一名单可以被医疗及相关团队用于评价自身提供的现有服务水平以及制定改进策略。

然而,作者同时也强调,这些推荐的服务类别能够最终整合入肿瘤治疗实践需要假以时日,而且,确定优先改善目标、制定有效的质量指标和基准、规范整个肿瘤姑息治疗服务设置、并更好地确定患者及家属姑息治疗的需求等问题,都需要进行更多的研究。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2034250, encodeId=a45c20342502c, content=<a href='/topic/show?id=1fe6828956d' target=_blank style='color:#2F92EE;'>#肿瘤姑息治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82895, encryptionId=1fe6828956d, topicName=肿瘤姑息治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Mon Jun 06 23:01:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938516, encodeId=8ba61938516f1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Fri Jan 22 07:01:00 CST 2016, time=2016-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38375, encodeId=8c09383e516, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:50:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626616, encodeId=16f6162661681, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Oct 11 00:01:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2034250, encodeId=a45c20342502c, content=<a href='/topic/show?id=1fe6828956d' target=_blank style='color:#2F92EE;'>#肿瘤姑息治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82895, encryptionId=1fe6828956d, topicName=肿瘤姑息治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Mon Jun 06 23:01:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938516, encodeId=8ba61938516f1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Fri Jan 22 07:01:00 CST 2016, time=2016-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38375, encodeId=8c09383e516, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:50:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626616, encodeId=16f6162661681, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Oct 11 00:01:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
    2016-01-22 quxin068
  3. [GetPortalCommentsPageByObjectIdResponse(id=2034250, encodeId=a45c20342502c, content=<a href='/topic/show?id=1fe6828956d' target=_blank style='color:#2F92EE;'>#肿瘤姑息治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82895, encryptionId=1fe6828956d, topicName=肿瘤姑息治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Mon Jun 06 23:01:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938516, encodeId=8ba61938516f1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Fri Jan 22 07:01:00 CST 2016, time=2016-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38375, encodeId=8c09383e516, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:50:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626616, encodeId=16f6162661681, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Oct 11 00:01:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
    2015-10-11 hlycom3356

    感谢作者分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2034250, encodeId=a45c20342502c, content=<a href='/topic/show?id=1fe6828956d' target=_blank style='color:#2F92EE;'>#肿瘤姑息治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82895, encryptionId=1fe6828956d, topicName=肿瘤姑息治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Mon Jun 06 23:01:00 CST 2016, time=2016-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938516, encodeId=8ba61938516f1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Fri Jan 22 07:01:00 CST 2016, time=2016-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38375, encodeId=8c09383e516, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 20:50:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626616, encodeId=16f6162661681, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Oct 11 00:01:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]

相关资讯

Guardian:口腔性行为与喉癌有关?

Michael Douglas: "because, without wanting to get too specific, this particular cancer is caused by HPV, which actually comes about from cunnilingus." 多年来,人们认为吸烟和饮酒是导致喉癌的主要危险因素。但是,周一,英国报纸《卫报》(Th